Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

If anything, the gap understates the gulf between the soft-spoken, beetle-browed Hoffmann, who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the ...

MOJEC International Limited has said that it deployed no fewer than 300,000 electricity meters in 2024. The company said it has reaffirmed its position as the largest smart meter manufacturer in s ...

If you watched this year's iPhone launch event, you could've been forgiven for thinking that the iPhone XS is the most underwhelming 'S' upgrade in the iPhone's history. Apple spent surprisingly ...

If you watched this year's iPhone launch event, you could've been forgiven for thinking that the iPhone XS is the most underwhelming 'S' upgrade in the iPhone's history. Apple spent surprisingly ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

"I think when companies come in and dump their products in the United States, they should pay automatically, let's say a 10% tax." ...

Around 600,000 households will be forced to install a smart meter or face higher bills within six months, as the BBC shuts down a 40-year-old radio service. The Radio Teleswitch Service (RTS), which ...